Cargando…

Modeling the progression of Type 2 diabetes with underlying obesity

Environmentally induced or epigenetic-related beta-cell dysfunction and insulin resistance play a critical role in the progression to diabetes. We developed a mathematical modeling framework capable of studying the progression to diabetes incorporating various diabetogenic factors. Considering the h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Boya, Li, Jiaxu, Haller, Michael J., Schatz, Desmond A., Rong, Libin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997875/ https://www.ncbi.nlm.nih.gov/pubmed/36848379 http://dx.doi.org/10.1371/journal.pcbi.1010914

Ejemplares similares

The progression of secondary diabetes: A review of modeling studies
por: Yang, Boya, et al.
Publicado: (2022)

Understanding Pre-Type 1 Diabetes: The Key to Prevention
por: Jacobsen, Laura M., et al.
Publicado: (2018)

Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 Diabetes
por: Mathews, Clayton E., et al.
Publicado: (2015)

Progressive Erosion of β-Cell Function Precedes the Onset of Hyperglycemia in the NOD Mouse Model of Type 1 Diabetes
por: Ize-Ludlow, Diego, et al.
Publicado: (2011)

Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2012)

Response to Comment on: Greenbaum et al. Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes. Diabetes 2012;61:1323–1330
por: Greenbaum, Carla J., et al.
Publicado: (2012)

Vitamin D Levels in Subjects With and Without Type 1 Diabetes Residing in a Solar Rich Environment
por: Bierschenk, Lindsey, et al.
Publicado: (2009)

How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
por: Haller, Michael J., et al.
Publicado: (2021)

339 A serum exocrine enzyme as a biomarker of response to immunotherapy in type 1 diabetes.
por: Bruggeman, Brittany S, et al.
Publicado: (2022)

It's Time to Mow the GRAS in Type 1 Diabetes
por: Schatz, Desmond A., et al.
Publicado: (2011)

Enhancing the Understanding of Pre-Type 1 Diabetes in the General Population
por: Simell, Olli, et al.
Publicado: (2010)

Transition Education for Young Adults With Type 1 Diabetes: Pilot Feasibility Study for a Group Telehealth Intervention
por: Albanese-O'Neill, Anastasia, et al.
Publicado: (2018)

Erratum. 2016 Presidential Address: Diabetes at 212°—Confronting the Invisible Disease. Diabetes Care 2016;39:1657–1663
por: Schatz, Desmond
Publicado: (2017)

The pancreas in human type 1 diabetes
por: Rowe, Patrick A., et al.
Publicado: (2010)

Serum Trypsinogen Levels in Type 1 Diabetes
por: Li, Xia, et al.
Publicado: (2017)

A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 (DPT-1) Participants
por: Sosenko, Jay M., et al.
Publicado: (2011)

Proposal for generating new beta cells in a muted immune environment for type 1 diabetes
por: Levetan, Claresa, et al.
Publicado: (2013)

Mechanism of immune attack in the progression of obesity-related type 2 diabetes
por: Wang, Hua-Wei, et al.
Publicado: (2023)

Designing Online and Mobile Diabetes Education for Fathers of Children With Type 1 Diabetes: Mixed Methods Study
por: Albanese-O'Neill, Anastasia, et al.
Publicado: (2019)

Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method
por: Tao, Betty, et al.
Publicado: (2010)

Reduced Serum Vitamin D–Binding Protein Levels Are Associated With Type 1 Diabetes
por: Blanton, Dustin, et al.
Publicado: (2011)

Fecal microbiota transplantation alters the susceptibility of obese rats to type 2 diabetes mellitus
por: Zhang, Lijing, et al.
Publicado: (2020)

Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes
por: Xue, Song, et al.
Publicado: (2015)

Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes
por: Ji, Ming, et al.
Publicado: (2016)

Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes
por: Haller, Michael J., et al.
Publicado: (2009)

Disparities in Social Support Systems for Youths With Type 1 Diabetes
por: Walker, Ashby F., et al.
Publicado: (2015)

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
por: Sosenko, Jay M., et al.
Publicado: (2020)

Diabetic Complications in Obese Type 2 Diabetic Rat Models
por: Katsuda, Yoshiaki, et al.
Publicado: (2014)

Type 1 diabetes through two lenses: comparing adolescent and parental perspectives with photovoice
por: Walker, Ashby, et al.
Publicado: (2016)

Increased Complement Activation in Human Type 1 Diabetes Pancreata
por: Rowe, Patrick, et al.
Publicado: (2013)

Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes Diagnosis
por: Williams, MacKenzie D., et al.
Publicado: (2021)

Modeling the dynamics of glucose, insulin, and free fatty acids with time delay: The impact of bariatric surgery on type 2 diabetes mellitus
por: Murillo, Anarina L., et al.
Publicado: (2019)

Distribution of C-Peptide and Its Determinants in North American Children at Risk for Type 1 Diabetes
por: Xu, Ping, et al.
Publicado: (2014)

Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling
por: Perry, Daniel J., et al.
Publicado: (2018)

Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes
por: Shi, Tingting, et al.
Publicado: (2021)

Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Orban, Tihamer, et al.
Publicado: (2009)

Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes
por: Jacobsen, Laura M., et al.
Publicado: (2020)

Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes
por: Campbell-Thompson, Martha, et al.
Publicado: (2016)

Differential Effect of Generalized and Abdominal Obesity on the Development and Progression of Diabetic Retinopathy in Chinese Adults With Type 2 Diabetes
por: Han, Xiaoyan, et al.
Publicado: (2022)

Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes
por: Liu, Jie-Ru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4hecvdofikv6luj0i1clg87t0h